RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
109 hedge funds and large institutions have $554M invested in Revance Therapeutics, Inc. in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 50 increasing their positions, 22 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
13% less call options, than puts
Call options by funds: $1.41M | Put options by funds: $1.61M
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
Holders
109
Holding in Top 10
2
Calls
$1.41M
Puts
$1.61M
Top Buyers
| 1 | +$6.77M | |
| 2 | +$2.55M | |
| 3 | +$2.5M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$2.34M |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$1.87M |
Top Sellers
| 1 | -$15.3M | |
| 2 | -$6.13M | |
| 3 | -$5.91M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.3M |